San Francisco Sentry Investment Group’s Natus Medical Inc NTUS Stock Holding History

San Francisco Sentry Investment Group’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-905	Closed	-$30K	–	907
2018 Q1	$30K	Sell	905 -2,380	-72%	-$75.3K	0.01%	521
2017 Q4	$125K	Sell	3,285 -1,890	-37%	-$75.5K	0.04%	327
2017 Q3	$194K	Sell	5,175 -150	-3%	-$5.29K	0.07%	247
2017 Q2	$199K	Sell	5,325 -180	-3%	-$6.5K	0.07%	223
2017 Q1	$216K	Buy	+5,505	New	+$207K	0.12%	180

Other funds holding NTUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

San Francisco Sentry Investment Group's NTUS Position: Q2 2018 in Review

San Francisco Sentry Investment Group sold out of Natus Medical Inc (NTUS) in Q2 2018, closing a stake of 905 shares — an estimated $30K sold.

San Francisco Sentry Investment Group first reported a position in NTUS in Q1 2017 and held it in 5 quarters. The position peaked at $216K in Q1 2017. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2018.

San Francisco Sentry Investment Group reported no remaining Natus Medical Inc position as of Q2 2018 after selling out during the quarter.
San Francisco Sentry Investment Group sold 905 Natus Medical Inc shares in Q2 2018, an estimated $30K.
San Francisco Sentry Investment Group first reported a position in Natus Medical Inc in Q1 2017 and held it in 5 quarters.
San Francisco Sentry Investment Group's Natus Medical Inc position peaked at $216K in Q1 2017.
175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2018, filed 6 Aug 2018.